These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7625483)

  • 21. Hyperammonemia with valproic acid therapy.
    Coulter DL; Allen RJ
    J Pediatr; 1981 Aug; 99(2):317-9. PubMed ID: 6788925
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitine for valproic acid-induced hyperammonemia.
    Raby WN
    Am J Psychiatry; 1997 Aug; 154(8):1168-9. PubMed ID: 9247410
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma.
    Hantson P; Grandin C; Duprez T; Nassogne MC; Guérit JM
    Eur Radiol; 2005 Jan; 15(1):59-64. PubMed ID: 15647953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute changes of blood ammonia may predict short-term adverse effects of valproic acid.
    Zaccara G; Campostrini R; Paganini M; Moroni F; Valenza T; Targioni G; Arnetoli G; Zappoli R; Baruzzi A
    Neurology; 1984 Nov; 34(11):1519-21. PubMed ID: 6436733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Valproate-induced hyperammonemic encephalopathy].
    Diaz-Rangel M; Grande-Martin A; Monsalve-Naharro JA; Domingo-Chiva E; Cuesta-Montero P; Lopez-Perez A
    Rev Neurol; 2017 Dec; 65(12):574-575. PubMed ID: 29235622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.
    Kulick SK; Kramer DA
    Ann Emerg Med; 1993 Mar; 22(3):610-2. PubMed ID: 8192712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
    Ettlin T; Scollo-Lavizzari G
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
    [No Abstract]   [Full Text] [Related]  

  • 29. Valporic acid and coma.
    Koskiniemi M; Hakamies L
    Neurology; 1979 Oct; 29(10):1430. PubMed ID: 384297
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sodium valproate, hyperammonemia and hepatic encephalopathy].
    Imler M; Warter JM; Marescaux C
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1042. PubMed ID: 6819177
    [No Abstract]   [Full Text] [Related]  

  • 31. Valproate-induced coma with ketosis and carnitine insufficiency.
    Triggs WJ; Bohan TP; Lin SN; Willmore LJ
    Arch Neurol; 1990 Oct; 47(10):1131-3. PubMed ID: 2121122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coma probably induced by lorazepam-valproate interaction.
    Lee SA; Lee JK; Heo K
    Seizure; 2002 Mar; 11(2):124-5. PubMed ID: 11945099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Encephalopathy with asterixis induced by sodium valproate. Role of hyperammonemia without hepatic insufficiency].
    Gastaut JL; Mege JL
    Presse Med; 1985 Feb; 14(7):431. PubMed ID: 3157141
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves.
    Kifune A; Kubota F; Shibata N; Akata T; Kikuchi S
    Epilepsia; 2000 Jul; 41(7):909-12. PubMed ID: 10897167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid and secondary hyperammonemia.
    Rawat S; Borkowski WJ; Swick HM
    Neurology; 1981 Sep; 31(9):1173-4. PubMed ID: 6791053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
    Bøhmer T; Bøen A; Høymork SC
    Scand J Gastroenterol; 2010 Jun; 45(6):762-3. PubMed ID: 20163200
    [No Abstract]   [Full Text] [Related]  

  • 38. Massive valproic acid overdose, a misleading case.
    Sikma MA; Mier JC; Meulenbelt J
    Am J Emerg Med; 2008 Jan; 26(1):110.e3-6. PubMed ID: 18082799
    [No Abstract]   [Full Text] [Related]  

  • 39. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
    Coulter DL; Allen RJ
    Lancet; 1980 Jun; 1(8181):1310-1. PubMed ID: 6104123
    [No Abstract]   [Full Text] [Related]  

  • 40. Valproate-associated hyperammonemia and DL-carnitine supplement.
    Komatsu M; Kodama S; Yokoyama S; Konishi H; Tanaka K; Momota K; Wada H; Matsuo T
    Kobe J Med Sci; 1987 Jun; 33(3):81-7. PubMed ID: 2959815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.